This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
Category: Composite tissue
NEW WEBINAR in collaboration with Transplant International

A new paper published in Transplant International, titled “Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation—Adjusting the Odds?”, discusses these additional parameters in further detail.
To mark the publication of this article, we are delighted to host a webinar with authors of the paper and leading experts from the field.
ESOT Congress 2021: Abstract Submission Deadline EXTENDED

The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
The COVID-19 Vaccine Studies

Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
Transplant International is looking for its publishing partner

ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
Scientific Highlights – Transplantation Learning Journey TLJ 2.0

We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the World’s leading transplant experts. Read the TLJ20Report for the
ESOT Congress 2021 – Submit your abstract next week and receive feedback!

ESOT is pleased to announce a new initiative in collaboration with the Centre for Evidence in Transplantation (CET), allowing 40 prospective abstract submitters to receive preliminary feedback on their abstract to help enhance the quality and increase the chances of being accepted to the Congress. Please see the process and deadlines below: Any prospective abstract
Registrations for HESPERIS are now open

We are delighted to inform you that the 2021 edition of the Hesperis course will take place online, in an innovative and exciting format. Learn more about the features that make Hesperis 2021 a unique educational opportunity for emerging professionals: from anywhere across Europe and beyond, learners will be able to gain an extensive overview
It’s time to prepare your abstract submission for #ESOTcongress

The ESOT Congress serves as a premier platform for researchers from across the globe to present their organ transplantation research, the abstract submission is open, with the following key submission deadlines: Abstract submission: 22 February 2021 Late-breaking abstract submission period: 10-25 May 2021 (preliminary research must be provided by 22 February 2021) Find out more by reading our abstract and clinical
ESOT Leonardo Da Vinci Transplant Research Innovation Award

This is the most prestigious scientific award at the ESOT Congress, stimulating an unprecedented and innovative approach to research. There are two winners of this award; one for ???????????????????????????????? ???????????????????????????????? and one for ???????????????????? ???????? ???????????????????????????????????????????????????? ????????????????????????????. Prior to the congress, eight outstanding contributions are selected from all of the scientific abstracts submitted to the